</s><s><s><s> human papillomavirus ( hpv ) type 6/11/16/18 recombinant vaccine ( gardasil ) was approved by the advisory committee on immunization practices in the united states in 2013. 
 the purpose of this review is to provide an overview of the literature on the safety and efficacy of this vaccine, as well as its use in the prevention and treatment of hiv-1-infected men and women, and their children, and to provide a summary of vaccine safety and immunogenicity in men and young women. </s>